Search
Oramed Pharmaceuticals Inc
ORMPAdd to Watchlist
4.600USD
-0.010-0.22%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
188.26MMarket Cap
1.72P/E TTM
Oramed Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Oramed Pharmaceuticals Inc is 8.96, ranking 72 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is 1.72, which is 1417.30% below the recent high of 26.12 and 911.63% above the recent low of -13.97.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.